BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29065872)

  • 1. QuaDMutEx: quadratic driver mutation explorer.
    Bokhari Y; Arodz T
    BMC Bioinformatics; 2017 Oct; 18(1):458. PubMed ID: 29065872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
    Bokhari Y; Alhareeri A; Arodz T
    BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo discovery of mutated driver pathways in cancer.
    Vandin F; Upfal E; Raphael BJ
    Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying overlapping mutated driver pathways by constructing gene networks in cancer.
    Wu H; Gao L; Li F; Song F; Yang X; Kasabov N
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 25859819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous identification of multiple driver pathways in cancer.
    Leiserson MD; Blokh D; Sharan R; Raphael BJ
    PLoS Comput Biol; 2013; 9(5):e1003054. PubMed ID: 23717195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A NOVEL AND EFFICIENT ALGORITHM FOR DE NOVO DISCOVERY OF MUTATED DRIVER PATHWAYS IN CANCER.
    Liu B; Wu C; Shen X; Pan W
    Ann Appl Stat; 2017 Sep; 11(3):1481-1512. PubMed ID: 29479394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequential Monte Carlo algorithm for inference of subclonal structure in cancer.
    Ogundijo OE; Zhu K; Wang X; Anastassiou D
    PLoS One; 2019; 14(1):e0211213. PubMed ID: 30682127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient methods for identifying mutated driver pathways in cancer.
    Zhao J; Zhang S; Wu LY; Zhang XS
    Bioinformatics; 2012 Nov; 28(22):2940-7. PubMed ID: 22982574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of constrained cancer driver genes based on mutation timing.
    Sakoparnig T; Fried P; Beerenwinkel N
    PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
    Merid SK; Goranskaya D; Alexeyenko A
    BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
    Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
    Elife; 2021 Jan; 10():. PubMed ID: 33427197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MaxCLK: discovery of cancer driver genes via maximal clique and information entropy of modules.
    Liu J; Ma F; Zhu Y; Zhang N; Kong L; Mi J; Cong H; Gao R; Wang M; Zhang Y
    Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38065693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulated annealing based algorithm for identifying mutated driver pathways in cancer.
    Li HT; Zhang YL; Zheng CH; Wang HQ
    Biomed Res Int; 2014; 2014():375980. PubMed ID: 24982873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of mutated driver pathways in cancer using a multi-objective optimization model.
    Zheng CH; Yang W; Chong YW; Xia JF
    Comput Biol Med; 2016 May; 72():22-9. PubMed ID: 26995027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of driver pathways in cancer based on combinatorial patterns of somatic gene mutations.
    Li HT; Zhang J; Xia J; Zheng CH
    Neoplasma; 2016; 63(1):57-63. PubMed ID: 26639234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CanDrA: cancer-specific driver missense mutation annotation with optimized features.
    Mao Y; Chen H; Liang H; Meric-Bernstam F; Mills GB; Chen K
    PLoS One; 2013; 8(10):e77945. PubMed ID: 24205039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
    Fleck JL; Pavel AB; Cassandras CG
    BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts.
    Jiang L; Zheng J; Kwan JSH; Dai S; Li C; Li MJ; Yu B; To KF; Sham PC; Zhu Y; Li M
    Nucleic Acids Res; 2019 Sep; 47(16):e96. PubMed ID: 31287869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
    Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
    BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.